Similar Articles
161 Advanced hepatocellular carcinoma treatment strategies: Are transarterial approaches leading the way?
162 Trends of alkaline phosphatase to prealbumin ratio in patients with hepatitis B linked to hepatocellular carcinoma development
163 Loss-of-function mutations of microRNA-142-3p promote ASH1L expression to induce immune evasion and hepatocellular carcinoma progression
164 Prognostic value of preoperative systemic immune-inflammation index/albumin for patients with hepatocellular carcinoma undergoing curative resection
165 N6-methyladenosine-modified long non-coding RNA KIF9-AS1 promotes stemness and sorafenib resistance in hepatocellular carcinoma by upregulating SHOX2 expression
166 Targeting hypoxia and angiogenesis in hepatocellular carcinoma: New insights and therapeutic strategies
167 Landscape of transarterial chemoembolization represented interventional therapy for hepatocellular carcinoma
168 Enhancing global hepatocellular carcinoma management: Bridging Eastern and Western perspectives on dexamethasone and N-acetylcysteine before transarterial chemoembolization
169 Statins decrease the risk of hepatocellular carcinoma in metabolic dysfunction-associated steatotic liver disease: A systematic review and meta-analysis
170 Hepatocellular carcinoma national burden across different geographical regions in the United States between 2001 and 2020
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA